| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Lundberg Sven Ante is a Chief Scientific Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $28.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2016 | CRSP Crispr Therapeutics AG | Chief Scientific Officer | Buy | 400 | $14.00 | $5,600.00 | - |